(Date:12/2/2009)...NILA, Philippines, Dec. 2 Spectrum...ing green energy companies on the planet. Through ...een Planet,s President and Recycling Specialist Le...ss for over 25 years, stated that Spectrum Blue St...g the stage for spectacular earnings because of th...
(Date:12/2/2009)...NEW YORK, Dec. 2 Nearly...cy makers, and funders today convened to explore n... strategies at the inaugural Partnering for Cures...sed center of the Milken Institute, convened Part...borations needed to turn a scientific discovery in...
(Date:12/2/2009)... LIBREVILLE, Gabon, December 2 ...veryone,s Problem and Heritage" , Coincid...-3 June 2010 the,Gabonese Republic is hosting an i...he issue of safeguarding biological resources in A...nt and state leaders, ministers,scientific expert...
(Date:12/2/2009)..., SINGAPORE, Dec. 2 S*BIO Pte L... oral JAK2 inhibitor, SB1518, at The American Soci...on in New Orleans. ,, Data will be presented on...tion trial of SB1518 detailing its safety, tolerab...profile in dose levels ranging from 100 to 600 mg....
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5...llars, QUEBEC CITY, Nov. 13 /PRNewswire-FirstCall...Z), a global biopharmaceutical company focused on,...al and operating results,for the third quarter end...ights, - Appointment on September 1, 2008, of Jue...na Zentaris, replacing Juergen Ernst who had been ...
...eduction in loss for the quarter, SAN JOSE, Calif...lletin Board: EROX) ("HPS" or "the Company") today...months ended September 30,2008. For the three mont...f,$262,000 represented a 10% increase from the rev...sulted in a net loss of $30,000 ($.01 per share),a...
...s professor Apparao Rao and his team are researchi...to read and alert us to toxic chemicals or gases i...nd the potential is there for real-time chemical a...ven at home. , "The ability to build extremely sm...ve only seen so far in science-fiction movies," Ra...
Other Biology Technology:AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 2AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 3AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 4AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 5AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 6AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 7AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 8AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 9Human Pheromone Sciences Announces Third Quarter Results 2Human Pheromone Sciences Announces Third Quarter Results 3Human Pheromone Sciences Announces Third Quarter Results 4Clemson researchers advance nanoscale electromechanical sensors 2Anti-G Protein Gi-alpha-1 Monoclonal Antibody, Unconjugated, Clone R4 from CHEMICON
Anti-VEGF Receptor-2 (FLK-1, KDR), phospho (Tyr996) Antibody, Unconjugated from CHEMICON
Rat IgG2b Clone: A95-1, Allophycocyanin Conjugated/Tagged from BD Biosciences Pharmingen
Mouse Oligodendrocyte Differentiation Kit from R&D Systems
Biology Products: